These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34666009)

  • 1. Production and characterization of novel monoclonal antibodies against outer membrane protein A (OmpA) of Acinetobacter baumannii.
    Yeganeh O; Shabani M; Pakzad P; Mosaffa N; Hashemi A
    J Immunol Methods; 2021 Dec; 499():113169. PubMed ID: 34666009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation the reactivity of a peptide-based monoclonal antibody derived from OmpA with drug resistant pulsotypes of Acinetobacter baumannii as a potential therapeutic approach.
    Yeganeh O; Shabani M; Pakzad P; Mosaffa N; Hashemi A
    Ann Clin Microbiol Antimicrob; 2022 Jun; 21(1):30. PubMed ID: 35773688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
    Wang-Lin SX; Olson R; Beanan JM; MacDonald U; Balthasar JP; Russo TA
    Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28947651
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
    Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
    Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model.
    Tamehri M; Rasooli I; Pishgahi M; Jahangiri A; Ramezanalizadeh F; Banisaeed Langroodi SR
    Microb Pathog; 2022 Dec; 173(Pt A):105874. PubMed ID: 36356792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of monoclonal antibodies for rapid detection of Acinetobacter baumannii.
    Baig A; Cabral TM; Corbett CR
    Monoclon Antib Immunodiagn Immunother; 2014 Aug; 33(4):291-8. PubMed ID: 25171011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection.
    Jahangiri A; Owlia P; Rasooli I; Salimian J; Derakhshanifar E; Aghajani Z; Abdollahi S; Khalili S; Talei D; Eslam ED
    Sci Rep; 2021 Jan; 11(1):1914. PubMed ID: 33479293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii.
    Vieira de Araujo AE; Conde LV; da Silva Junior HC; de Almeida Machado L; Lara FA; Chapeaurouge A; Pauer H; Pires Hardoim CC; Martha Antunes LC; D'Alincourt Carvalho-Assef AP; Moreno Senna JP
    Microbes Infect; 2021; 23(4-5):104801. PubMed ID: 33582283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii.
    Lin MF; Tsai PW; Chen JY; Lin YY; Lan CY
    PLoS One; 2015; 10(10):e0141107. PubMed ID: 26484669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Level of Antibodies Against Novel Acinetobacter Baumannii OmpA-selected Peptides in ICU Staff: Promise for the Future of Vaccine Development.
    Paydarfar S; Abbasi MA; Hashemi A; Taheri S; Bandehpour M; Mosaffa N
    Iran J Allergy Asthma Immunol; 2023 Apr; 22(2):150-162. PubMed ID: 37496408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model.
    Jahangiri A; Owlia P; Rasooli I; Salimian J; Derakhshanifar E; Naghipour Erami A; Darzi Eslam E; Darvish Alipour Astaneh S
    J Appl Microbiol; 2019 Feb; 126(2):624-632. PubMed ID: 30353977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of outer membrane protein H (OmpH)- and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida.
    Vasfi Marandi M; Mittal KR
    Infect Immun; 1997 Nov; 65(11):4502-8. PubMed ID: 9353026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice.
    Mehdinejadiani K; Bandehpour M; Hashemi A; Ranjbar MM; Taheri S; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):655-663. PubMed ID: 32245309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
    Singh R; Capalash N; Sharma P
    Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of antigens from nosocomial Acinetobacter baumannii clinical isolates in sera from ICU staff and infected patients using the antigenome technique.
    Nafarieh T; Bandehpour M; Hashemi A; Taheri S; Yardel V; Jamaati H; Moosavi SM; Mosaffa N
    World J Microbiol Biotechnol; 2017 Sep; 33(10):189. PubMed ID: 28965283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antibacterial activity of Zataria multiflora Boiss extract and its components, carvacrol, and thymol, against colistin-resistant Acinetobacter baumannii in a pneumonic BALB/c mouse model.
    Hassannejad N; Bahador A; Rudbari NH; Modarressi MH; Parivar K
    J Cell Biochem; 2019 Nov; 120(11):18640-18649. PubMed ID: 31338900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
    Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibody Therapy against
    Nielsen TB; Yan J; Slarve M; Lu P; Li R; Ruiz J; Lee B; Burk E; Talyansky Y; Oelschlaeger P; Hurth K; Win W; Luna BM; Bonomo RA; Spellberg B
    Infect Immun; 2021 Sep; 89(10):e0016221. PubMed ID: 34310884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.